Chandan Kumar Kedarisetty
Overview
Explore the profile of Chandan Kumar Kedarisetty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Yalaka R, Sameer Kumar G, Mogili K, Kedarisetty C, Yalakanti R
Endoscopy
. 2023 Aug;
55(S 01):E996-E997.
PMID: 37604445
No abstract available.
3.
Yalaka R, Kedarisetty C, Narayankar S, Mogili K, Shepur M, Vangara S
Endoscopy
. 2021 Oct;
54(9):E522-E523.
PMID: 34695850
No abstract available.
4.
Govindarajan R, Ramamoorthy G, Shanmugam R, Bavanandam S, Murugesan M, Shanmugam C, et al.
Indian J Gastroenterol
. 2021 Jun;
40(4):373-379.
PMID: 34189713
Background And Aim: Though rodenticidal hepatotoxicity is reported from India, there is no systematic study to assess its magnitude. This study aimed to assess exposure to rodenticide as a risk...
5.
Premkumar M, Kedarisetty C
J Clin Transl Hepatol
. 2021 May;
9(2):256-264.
PMID: 34007808
The coronavirus pandemic has resulted in increased rates of hepatic decompensation, morbidity and mortality in patients suffering from existing liver disease, and deranged liver biochemistries in those without liver disease....
6.
Kedarisetty C, Bhardwaj A, Kumar G, Rastogi A, Bihari C, Kumar M, et al.
Indian J Gastroenterol
. 2021 Mar;
40(1):41-49.
PMID: 33772456
Background And Aim: Non-alcoholic steatohepatitis (NASH) is the most prevalent cause of chronic liver disease. Vitamin E (VE), an anti-oxidant, has shown improvement in NAFLD activity score (NAS) but not...
7.
Kedarisetty C, Kumar A, Sarin S
Semin Liver Dis
. 2021 Mar;
41(1):67-78.
PMID: 33764486
Alcohol use disorder is the predominant cause of chronic liver disease globally. The standard of care for the treatment of alcoholic hepatitis, corticosteroids, has been shown to provide a therapeutic...
8.
Malleeswaran S, Mohanka R, Yalakanti R, Patcha R, Rao P, Appusamy E, et al.
Transplantation
. 2021 Mar;
105(7):e70-e71.
PMID: 33724249
No abstract available.
9.
Kedarisetty C, Samaga B, Vidyasagar S, Venkataraman J
J Infect Dev Ctries
. 2020 Dec;
14(11):1327-1331.
PMID: 33296347
Introduction: Malaria is a growing global threat and a major cause of mortality in the tropics. The gold standard diagnosis is peripheral blood smear examination. It has been demonstrated that...
10.
Kedarisetty C, Kumar R
Cureus
. 2020 Oct;
12(9):e10568.
PMID: 33110713
Acute-on-chronic liver failure (ACLF) is characterized by acute decompensation of chronic liver disease associated with organ failures. Anemia of diverse etiology is common in patients with ACLF. Spur cell anemia...